Pharmacodynamics and Innovative Therapeutic Strategies for Metabolic Disorders
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Pharmacology and Drug Metabolism".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 81
Special Issue Editors
Interests: pharmacology; experimental therapeutics; metabolic diseases; drug development; therapeutic innovations; metabolic pathways; drug mechanism
Special Issues, Collections and Topics in MDPI journals
Interests: plant bioactive compounds; chemical analysis; pharmacology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metabolic diseases, including diabetes, obesity, and cardiovascular conditions, represent a growing global health challenge, necessitating the development of novel pharmacological approaches and therapeutic interventions. This Special Issue invites contributions focused on the latest advancements in pharmacology and experimental therapeutics aimed at addressing these disorders. The Special Issue seeks to provide an interdisciplinary platform for researchers working at the intersection of drug discovery, metabolic diseases, and therapeutic innovation.
The Special Issue will primarily focus on experimental therapies and pharmacological mechanisms that influence metabolic pathways, with an emphasis on novel drug development, preclinical studies, and clinical trials. Research exploring the pharmacokinetics and pharmacodynamics of new therapeutics for metabolic disorders is especially encouraged, alongside studies that provide insights into disease mechanisms and treatment strategies.
Dr. Josué V. Espinosa-Juárez
Dr. Osmar Antonio Jaramillo-Morales
Prof. Dr. Victor Gault
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacology
- experimental therapeutics
- metabolic diseases
- drug development
- therapeutic innovations
- metabolic pathways
- pharmacodynamics
- disease management
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
